News Releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Apr 23, 2015
RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx") today announced that it received a Notice of Allowance from the U.S. Patent and Trademark Office for its patent...
-
Apr 16, 2015
RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx") today announced its U.S. joint venture with G-treeBNT (ReGenTree LLC) has retained Ora, Inc. to conduct a phase 3...
-
Apr 1, 2015
RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx") today announced that a new medical paper has been published describing the positive effects of Thymosin beta 4 (TB4)...
-
Apr 1, 2015
RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx") today announced that a new medical paper has been published describing the positive effects of Thymosin beta 4 (TB4)...
-
Mar 26, 2015
RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX)("the Company" or "RegeneRx") today announced that it has received a patent acceptance notice from the Israeli patent office with claims for...